Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytosorbents Corp CTSO

Technology Scientific & Technical Instruments
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product... see more

Recent & Breaking News (NDAQ:CTSO)

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

PR Newswire May 29, 2025

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

PR Newswire May 22, 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

PR Newswire May 14, 2025

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

PR Newswire May 1, 2025

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

PR Newswire April 29, 2025

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

PR Newswire April 21, 2025

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

PR Newswire April 17, 2025

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

PR Newswire April 14, 2025

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

PR Newswire April 4, 2025

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

PR Newswire March 31, 2025

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

PR Newswire March 21, 2025

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

GlobeNewswire March 4, 2025

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire February 26, 2025

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

GlobeNewswire February 25, 2025

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

GlobeNewswire January 13, 2025

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

GlobeNewswire January 6, 2025

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

GlobeNewswire January 3, 2025

CytoSorbents Rights Offering Begins

GlobeNewswire December 23, 2024

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

GlobeNewswire December 12, 2024

CytoSorbents Announces Rights Offering

GlobeNewswire December 9, 2024